Streamlined, single-step non-viral CRISPR-Cas9 knockout strategy enhances gene editing efficiency in primary human chondrocyte populations.

MLA

Ponta, Simone, et al. “Streamlined, Single-Step Non-Viral CRISPR-Cas9 Knockout Strategy Enhances Gene Editing Efficiency in Primary Human Chondrocyte Populations.” Arthritis Research & Therapy, vol. 26, no. 1, Mar. 2024, p. 66. EBSCOhost, https://doi.org/10.1186/s13075-024-03294-w.

APA

Ponta, S., Bonato, A., Neidenbach, P., Bruhin, V. F., Laurent, A., Applegate, L. A., Zenobi-Wong, M., & Barreto, G. (2024). Streamlined, single-step non-viral CRISPR-Cas9 knockout strategy enhances gene editing efficiency in primary human chondrocyte populations. Arthritis Research & Therapy, 26(1), 66. https://doi.org/10.1186/s13075-024-03294-w

Chicago

Ponta, Simone, Angela Bonato, Philipp Neidenbach, Valentino F Bruhin, Alexis Laurent, Lee Ann Applegate, Marcy Zenobi-Wong, and Goncalo Barreto. 2024. “Streamlined, Single-Step Non-Viral CRISPR-Cas9 Knockout Strategy Enhances Gene Editing Efficiency in Primary Human Chondrocyte Populations.” Arthritis Research & Therapy 26 (1): 66. doi:10.1186/s13075-024-03294-w.